2002•The American Journal of MedicineRequires access

An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase

David M. Kent, Rodney A. Hayward, John L. Griffith, Sandeep Vijan, Joni R. Beshansky, Robert M. Califf, Harry P. Selker

Open publisher page 61 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 61 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Streptokinase, Medicine, Tissue plasminogen activator, Myocardial infarction, T-plasminogen activator, Fibrinolytic agent, Internal medicine, Thrombolysis

Back to paper search Browse research topics Original source

An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase — Research Paper | ScholarLens